EuroValve 2016 program

March 10 - 11, 2016 Hotel Bloom!, Brussels, BELGIUM www.eurovalvecongress.com

COURSE DIRECTORS Patrizio Lancellotti, Liege, Belgium Khalil Fattouch, Palermo, Italy Gilbert Habib, Marseille, France JosĂŠ Luis Zamorano, Madrid, Spain Raphael Rosenhek, Vienna, Austria

Scientific program endorsed by the EACVI and by the ESC Working Group on Valvular Heart Diseases

Edito Welcome to EuroValve 2016!

It is a great pleasure to welcome you for this fourth edition in Brussels, the n°1 destination for congresses in Europe, which offers you an exciting cultural, artistic and socialscene at sensible prices.

As you may know, we always intend to favour more interactivity and discussions, especially thanks to several symposia, industry symposia, controversies and round tables.

Again, over 2 days, we will present an extensive program dedicated to valvular heart disease, focusing on genetics, surgery, epidemiology, transcatheter valve replacement, echocardiography and new imaging.

This year, we are hosting the ePosters presentation on Thursday March 10 in the plenary room.

Take your time to visit the exhibition and discover the Industry news as it is only thanks to their precious help that we could achieve our ambitious program and do not miss Abbott Vascular and Siemens symposia in the plenary room.

We are very pleased to have you during two convivial days of fruitful teaching in Brussels.

Enjoy the congress!

The course directors Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano and Raphael Rosenhek

Scientific program endorsed by the EACVI and by the ESC Working Group on Valvular Heart Diseases

Faculty Jutta Bergler-Klein, Vienna, Austria Alain Berrebi, Paris, France Bernard Cosyns, Braine-L’Alleud, Belgium Michele De Bonis, Milan, Italy Jean-Olivier Defraigne, Liege, Belgium Laurent De Kerchove, Woluwe-Saint-Lambert, Belgium Victoria Delgado, Leiden, The Netherlands Alessandro Della Corte, Naples, Italy Erwan Donal, Rennes, France Gilles Dreyfus, Monaco Raluca Elena Dulgheru, Brussels, Belgium Arturo Evangelista Masip, Barcelona, Spain Madalina Garbi, London, United Kingdom Ariana González-Gómez, Madrid, Spain Bernard Iung, Paris, France Joëlle Kefer, Brussels, Belgium Philippe Kolh, Liege, Belgium Giovanni La Canna, Milan, Italy Victor Legrand, Liege, Belgium

Julien Magne, Limoges, France Gérald Maurer, Vienna, Austria Thomas Modine, Lille, France Jean-Luc Monin, Créteil, France Cécile Oury, Liege, Belgium Alessandro Parolari, Milan, Italy Agnes Pasquet, Brussels, Belgium Philippe Pibarot, Quebec, Canada Luc Piérard, Liege, Belgium Bernard Prendergast, London, United Kingdom Prakash P. Punjabi, London, United Kingdom Marc Radermecker, Liege, Belgium Natzi Sakalihasan, Liege, Belgium Maurice Sarano, Rochester, USA Pilar Tornos, Barcelona, Spain Philippe Unger, Brussels, Belgium Nico Van de Veire, Gent, Belgium Isidre Villacosta, Madrid, Spain

Synoptic THURSDAY MARCH 10 08:30 Opening ceremony

Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Raphael Rosenhek

FRIDAY MARCH 11 08:30 Innovation: new therapeutic approaches of valve disease Victoria Delgado, Luc Piérard

08:40 Symposium: the changing environment 09:00 Keynote Lecture Arturo Evangelista Masip, Natzi Sakalihasan of valve disease Patrizio Lancellotti, José Luis Zamorano

09:55 Keynote lecture Gilles Dreyfus, Gilbert Habib 10:15 Coffee break in the exhibition hall 10:45

09:40 Improving risk stratification in asymptomatic mitral regurgitation Jean-Olivier Defraigne, Jutta Bergler-Klein

Controversies in aortic regurgitation Victor Legrand, Alain Berrebi

11:25

11:10

Coffee break in the exhibition hall

11:40

Industry symposium

12:40

Does MitraClip have a survival benefit?

Industry symposium

13:10

Lunch break in the exhibition hall

Industry symposium Accuracy in valve measurements, what are the new trends?

12:25

13:25

Lunch break in the exhibition hall

ESC 2015 guidelines. Endocarditis: evolution or revolution?

Luc Piérard, Patrizio Lancellotti

14:05 Seminar TAVI: minimizing complications Patrizio Lancellotti, Gerald Maurer

14:45

Short Communications. Challenges in aortic stenosis Agnes Pasquet, Ariana González-Gómez

15:20 Challenges in the management secondary mitral regurgitation 16:00

Coffee break in the exhibition hall

16:30

Case presentations: challenges in infective endocarditis Gilbert Habib, José Luis Zamorano

17:30

Prakash P. Punjabi, Michele De Bonis, Gilbert Habib

16:35 Closing remarks and awards ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Raphael Rosenhek

Keynote lecture Khalil Fattouch, Arturo Evangelista Masip

18:00 19:10

e-Posters competition End of the sessions

www.eurovalvecongress.com

Thursday March 10, 2016 08:00

Welcome coffee in the exhibition hall

08:30 Opening ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Raphael Rosenhek 08:40 Symposium: the changing environment of valve disease

Chairmen: Patrizio Lancellotti, José Luis Zamorano 08:40 The epidemic of valvular disease, Maurice Sarano 09:00 Comorbidities and multiple valves: new challenges, Bernard Prendergast 09:20 The heart team and the heart valve clinic, Raphael Rosenhek 09:40 Round table discussion with expert’s panel: Luc Piérard, Philippe Pibarot, Jean-Luc Monin 09:55 Keynote lecture

Chairmen: Gilles Dreyfus, Gilbert Habib 09:55 Should we operate on tricuspid valve at the time of left-sided valve surgery?

Giovanni La Canna 10:05 Round table discussion with expert’s panel: Philippe Kolh, Khalil Fattouch, Nico Van de Veire, Alain Berrebi 10:15

Coffee break in the exhibition hall

10:45 Controversies in aortic regurgitation

Chairmen: Victor Legrand, Alain Berrebi 10:45 Paravalvular regurgitation is a risk factor following TAVI, Philippe Pibarot 11:05 Mild paravalvular regurgitation is not a risk factor following TAVI, Thomas Modine 11:25

11:25 11:40 11:55 12:10

Industry symposium Accuracy in valve measurements, what are the new trends?

2D Pitfalls in measurements in Mitral Regurgitation, Gilbert Habib How 3D can help, José Luis Zamorano The aortic valve. Do we need 3D? Ariana González-Gómez Do not forget left ventricle in valvulopathies, Julien Magne

12:25

Lunch break in the exhibition hall

13:25 ESC 2015 guidelines. Endocarditis: evolution or revolution?

Chairmen: Luc Piérard, Patrizio Lancellotti 13:25 Prophylaxis, Bernard Iung 13:40 Embolic risk, Patrizio Lancellotti 13:55 Diagnostic strategy, Pilar Tornos 14:10 Endocarditis team and surgical indications, Gilbert Habib 14:25 Round table discussion with expert’s panel Prakash P. Punjabi, Maurice Sarano, Raluca Elena Dulgheru, Philippe Unger 14:45 Short Communications. Challenges in aortic stenosis

Chairmen: Agnes Pasquet, Ariana González-Gómez 14:45 Why and what to say to the interventionists? José Luis Zamorano 15:00 Should we move toward low risk AS patients with TAVI? Joëlle Kefer 15:15 SAVR or TAVI in patients with previous CABG? Marc Radermecker 15:30 Is TAVI better than SAVR in patients with LV dysfunction? Philippe Pibarot 15:45 ”Valve in Valve” interventions: which is the appropriate patient to select? TBC 16:00

Coffee break in the exhibition hall

16:30 Case presentations: challenges in infective endocarditis

Chairmen: Gilbert Habib, José Luis Zamorano 16:30 Endocarditis in the intensive care, Bernard Cosyns 16:45 Pacemaker lead endocarditis, Isidre Villacosta 17:00 TAVI endocarditis, Gilbert Habib 17:15 Marantic endocarditis, Erwan Donal 17:30 Keynote lecture

Chairmen: Khalil Fattouch, Arturo Evangelista Masip 17:30 Aortic valve repair: state of the art? Laurent De Kerchove 17:45 Round table discussion with expert’s panel Natzi Sakalihasan, Alain Berrebi, Alessandro Della Corte 18:00 Eposters competition (p 8-11) Chairmen: Erwan Donal, Bernard Cosyns

www.eurovalvecongress.com

Friday March 11, 2016 08:00

Welcome coffee in the exhibition hall

08:30 Innovation: new therapeutic approaches of valve disease

Chairmen: Victoria Delgado, Luc Piérard 08:30 Percutaneous mitral valve repair, Khalil Fattouch 08:50 Round table discussion with expert’s panel Jose Luis Zamorano, Thomas Modine, Ariana González-Gómez 09:00 Keynote Lecture

Chairmen: Arturo Evangelista Masip, Natzi Sakalihasan 09:00 The bicuspid aortic valve, Jean-Luc Monin 09:20 Round table discussion with expert’s panel Agnes Pasquet, Khalil Fattouch 09:40 Improving risk stratification in asymptomatic mitral regurgitation

Chairmen: Jean-Olivier Defraigne, Jutta Bergler-Klein 09:40 Stress echocardiography, Raluca Elena Dulgheru 09:55 Neuro-hormones, Julien Magne 10:10 Myocardial fibrosis by MRI, Victoria Delgado 10:25 Watchful waiting? Raphael Rosenhek 10:40 Current gold standard in primary MV repair: importance of patient selection, Alessandro Parolari 10:55 Round discussion with expert’s panel Cécile Oury, Madalina Garbi 11:10

Coffee break in the exhibition hall

11:40

11:40 11:50 12:00 12:10 12:20

Industry symposium Does MitraClip have a survival benefit?

Chairman: José Luis Zamorano Introduction, José Luis Zamorano Who can benefit from the MitraClip Therapy? Philippe Debonnaire Does MitraClip have a survival benefit? Martin Swaans Patient management after MitraClip Therapy, Victoria Delgado Conclusions, José Luis Zamorano

12:40

Industry symposium Anatomical intelligence in Ultrasound, how technology meets clinical practice Endocarditis, Gilbert Habib MV, the 3D perspective, Patrizio Lancelloti HM and EF, clinical scenarios, José Luis Zamorano Fusion imaging in the Cath Lab, the real deal? José Luis Zamorano

13:10

Lunch break in the exhibition hall

14:05 Seminar TAVI: minimizing complications

Chairmen: Patrizio Lancellotti, Gerald Maurer 14:05 Vascular access, Joëlle Kefer 14:20 Stroke Michael, Thomas Modine 14:35 Permanent pacing, Joëlle Kefer 14:50 Paravalvular leak, José Luis Zamorano 15:05 Round discussion with expert’s panel Luc Piérard, Ariana González-Gómez 15:20 Challenges in the management secondary mitral regurgitation

Chairmen: Michele De Bonis, Gilbert Habib 15:20 Moderate or severe? Khalil Fattouch 15:35 Guidelines in perspective? Luc Piérard 15:50 Is there yet a place for surgical repair? Michele De Bonis 16:05 Reshape/Coapt: do we need more? Jose Luis Zamorano 16:20 Round discussion with expert’s panel Khalil Fattouch, Jutta Bergler-Klein 16:35 Closing remarks and awards ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Raphael Rosenhek

www.eurovalvecongress.com

ePosters competition 18:00 Novel design for bileaflet mechanical heart valves and its hemodynamic performance under physiological condition Nima Mirkhani1, Mohammad Reza Davoudi2, Pedram Hanafizadeh1, Daryoosh Javidi3, Niloofar Saffarian4

1. University of Tehran, Islamic Republic of Iran 2. Katholieke Universiteit Leuven, Belgium 3. Department of Cardiac Surgery, Pars Hospital, Tehran, Islamic Republic of Iran 4. Cardiovascular Department, Pars Hospital, Tehran, Islamic Republic of Iran

18:03 Heart sarcoma invasive mitral valve Redha Lakehal, Aimer Farid, Bouharagua Rabeh, Boutamina Lilya, khacha khaled, Boukharoucha Radouane, Bendjaballah Soumaya, Aziza Baya, Brahami Abdelmalek

Ehs el riadh, CONSTANTINE, Algeria

18:06 Thrombosis of heart valve prosthesis in pregnant women Redha Lakehal, Boukharoucha Radouane, Aimer Farid, Bouharagua Rabeh, Babouri Abdelrahmen, Boutamina Lilya, Aziza Baya, Bendjaballah Soumaya, Brahami Abdelmalek

Ehs el riadh, CONSTANTINE, Algeria

18:09 Prosthetic valve thrombosis Redha Lakehal, Boukharoucha Radouane, Aimer Farid, Bouharagua Rabeh, Brahami Abdelmalek

Ehs el riadh, CONSTANTINE, Algeria

18:12 Aortic valve repair versus replacement in laubry pezzi syndrome Redha Lakehal, Bouharagua Rabeh, Aimer Farid, Boukharoucha Radouane, Brahami Abdelmalek

Ehs el riadh, CONSTANTINE, Algeria

18:15 Epidemiological and clinical aspects of 88 cases with rheumatic mitral valve disease (RMD) Noura Elazaoui, Leila Azzouzi, Malika Noureddine, Rachida Habbal

CHU Ibn Rochd, Casablanca, Morocco

18:18 Brucella tricuspid endocarditis Redha Lakehal, Aimer Farid, Bouharagua Rabeh, Boukharoucha Radouane, Boukharoucha Radouane

Ehs el riadh, CONSTANTINE, Algeria

18:21

Posterior aortic enlargement in women with aortic annulus at 15 mm Redha Lakehal, Aimer Farid, Bouharagua Rabeh, Boukharoucha Radouane, Brahami Abdelmalek, Boukharoucha Radouane, Brahami Abdelmalek

Ehs el riadh, CONSTANTINE, Algeria

18:24 Rheumatic mitral stenosis in adult people in Casablanca (Morocco) Noura Elazaoui, Leila Azzouzi, Malika Noureddine, Rachida Habbal

CHU Ibn Rochd, Casablanca, Morocco

18:27 Transient acute mitral regurgitation (TAMR): a new entity responsible for acute heart failure in patients with preserved left ventricular ejection fraction Olivier Milleron1, Claire Bouleti1, Serge Mazouz2, Eric Brochet1, Whalid Ghodbane3, David Messika-Zeitoun1, Simon Cattan2, Alec Vahanian1, Bernard Iung1, Guillaume Jondeau1

1. Service de Cardiologie Hopital Bichat, Paris, France 2. Service de Cardiologie GHI Le Raincy-Montfermeil, France 3. Service de Chirurgie Cardiaque. Hôpital Bichat, Paris, France

18:30 Investigation of aortic mechanical heart valve effects on the coronary arteries flow rate and potential risk of the atherosclerosis Nima Mirkhani1, Mohammad Reza Davoudi2, Pedram Hanafizadeh1, Daryoosh Javidi3, Niloofar Saffarian4

1. University of Tehran, Islamic Republic of Iran

2. Katholieke Universiteit Leuven, Belgium 3. Department of Cardiac Surgery, Pars Hospital, Tehran, Islamic Republic of Iran 4. Cardiovascular Department, Pars Hospital, Tehran, Islamic Republic of Iran

18:33 Stress echocardiography: a very useful test in the management of patients with mitral valve stenosis Oriol de Diego Soler, Elena Ferrer Sistach, Nuria Vallejo Camazon, Jorge Lopez-Ayerbe, Albert Teis Soley, Francisco Gual Capllonch, Silvia Serrano Garcia, Eva Bernal Labrador, Gladys Junca Puig, Antoni BayesGenis

Hospital Universitari Germans Trias i Pujol, Badalona, Spain

18:36 Tricuspid tissue valve re-operation in patient with a normally functioning mechanical mitral valve

Sofija Popevska, Darko Anic

University Clinic for Cardiac Surgery Rebro, Zagreb, Croatia 18:39

Durability of mechanical mitral prosthesis: do we test the time?

Sofija Popevska

18:42

Fusion of x-ray and real time echocardiography during TAVI Ilaria Boretti, Ariana González-Gómez, Covadonga Fernández-Golfín, Luisa Salido-Tahoces, Rosa Ana Hernández-Antolín, Eduardo Casas-Rojo, Rocio Hinojar-Baydes, José Luis Zamorano

Department of Cardiology-Ramon y Cajal University Hospital, Madrid, Spain

University Clinic for Cardiac Surgery Rebro, Zagreb, Croatia

ePosters competition 18:45 Ball thrombus with recent cardioembolic stroke: case report and brief review of the literature Noura Elazaoui, Leila Azzouzi, Malika Noureddine, Rachida Habbal

CHU Ibn Rochd, Casablanca, Morocco 18:48 Characteristics and outcomes of asymptomatic severe aortic stenosis patients with preserved left ventricular ejection fraction according to the flow and gradient classification Carlos Izurieta, Juan Manuel Monteagudo-Ruiz, Ariana González-Gómez, Covadonga Fernández-Golfin, Ana García-Martín, Rocío Hinojar-Baydes, Eduardo Casas-Rojo, José Julio Jiménez-Nacher, José Luis Zamorano

Hospital Universitario Ramón y Cajal, Madrid, Spain 18:51 Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults William Miranda, Heidi Connolly, Crystal Bonnichsen, Daniel DeSimone, Joseph Dearani, Joseph Maleszewski, Kevin Greason, Walter Wilson, Larry Baddour

Mayo Clinic, Rochester, United States

18:54 Emergent surgery in infective endocarditis in a tertiary hospital Nuria Vallejo Camazon1, Xavier Armario1, Oriol de Diego1, Francisco Gual1, Albert Teis1, Jorge Lopez Ayerbe1, Cinta LLibre1, Lluisa Pedro Botet2, Raquel Nuñez Aragon2, Antoni Bayes Genis1

1. Cardiology. Hospital Germans TRias i Pujol, Barcelona, Spain

2. Infectious Diseases department.Hopsital Germans Trias i Pujol, Badalona, Spain

18:57 Clinical and epidemiological profile of native infective endocarditis in a tertiary center; outcome changes after multidisciplinary team aproach Nuria Vallejo1, Oriol De Diego1, Xavier Armario1, Lurdes Mateu2, Sonia Molinos3, Elisabet Berastegui4, Elena Ferrer1, Antoni Bayes Genis1

1. Cardiology department. Hospital Germans Trias i Pujol, Badalona, Spain

2. Infectious diseases. Hospital Germans TRias i Pujol, Badalona, Spain 3. Microbiology. Hospital Germans Trias i Pujol, Badalona, Spain 4. Cardiaca Surgery. Hospital Germans TRias i Pujol, Badalona, Spain

19:00 Pseudoaneurysm of valsalva sinus in a brucella infected native aortic valve

Daniela Teferici, Edvin Prifti, Amanda Lloji, Lidra Gjyli

UHC “Mother Theresa”, Tirana, Albania 19:10

End of the sessions

Notes ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ......................................................................

Stay alert Keep up to date with the highest quality material, both scientific and clinical, from all areas of cardiovascular imaging with email table of contents alerts from the European Heart Journal – Cardiovascular Imaging

At the heart of Cardiology Sign up under the ‘Stay Alert’ heading at: ehjcimaging.oxfordjournals.org

Information Congress venue: Hotel Bloom, Brussels, BELGIUM Rue Royale 250 1210 Brussels, Belgium Phone: +3222206611 www.hotelbloom.com REGISTRATION DESK OPENING HOURS Thursday March 10 Friday March 11

07.30 - 19.30 07.30 - 17.00

EVENT COORDINATORS’ CONTACTS Project manager Stéphanie Meyer

+ 33 646 10 48 26

Managing director Vérane Bergeron Moreau + 33 621 78 87 16

WHY NOT OFFER YOUR PATIENTS A VALVE

PROVEN TO PERFORM LIKE A NATIVE HEALTHY HEART VALVE? The Trifecta™ Valve from St. Jude Medical was designed to deliver exceptional hemodynamic performance and durability to stand the test of time. The Trifecta™ Valve consistently mimics the flow of a native healthy heart valve.

Bench testing predicted excellent hemodynamics and durability,1 while clinical data from a prospective multi-center study delivered the proof.2

PROMISE Exceptional hemodynamics PROVEN

PROMISE PROVEN

The lowest hemodynamic gradients in the market, size-for-size among tissue heart valves1,3-6 Excellent durability; 99.2% freedom from SVD at 5 years7 99.7% freedom from SVD at 5 years2

Learn more at sjm.com/trifecta

References 1. St. Jude Medical. Trifecta™ Valve. Pre-Market Approval Application Summary of Safety and Effectiveness Data. P100029. 2011.

2. St. Jude Medical. Trifecta™ Valve. Clinical Compendium. Five-Year Data. 2014. ID-2000385 B EN (06/14).

3. Edwards Lifesciences Corporation. Carpentier-Edwards Magna Ease™ Pericardial Aortic Bioprosthesis, Model 3300TFX. Instructions for Use. 2009. Echo follow-up at one year.

4. Medtronic, Inc. (ATS Medical). 3f™ Aortic Bioprosthesis. Pre-Market Approval Application Summary of Safety and Effectiveness Data, P060025. 2008. Echo follow-up at one year.

5. Medtronic, Inc. Medtronic Mosaic™ Porcine Bioprosthesis. Pre-Market Approval Application Summary of Safety and Effectiveness Data. P990064. 2000. Echo follow-up at one year.

6. CarboMedics, Inc., Sorin. Mitroflow™ Aortic Pericardial Heart Valve. Pre-Market Approval Application Summary of Safety and Effectiveness Data. P060038. 2007. Echo follow-up at one year.

7. St. Jude Medical. Trifecta™ Valve. 2010. Data on file.

Rx Only Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

Indications: The Trifecta™ Valve is indicated as a replacement for a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve. Adverse events potentially associated with the use of bioprosthetic heart valves include: angina, cardiac arrhythmias, endocarditis, heart failure, hemolysis, hemolytic anemia, hemorrhage, leak (transvalvular or perivalvular), myocardial infarction, nonstructural dysfunction (entrapment by pannus or suture, inappropriate sizing or positioning, or other), prosthesis regurgitation, stroke, structural deterioration (calcification, leaflet tear, perforation, or other), thromboembolism and valve thrombosis. It is possible that these complications could lead to reoperation, explantation, permanent disability or death. Long-term low dose aspirin, unless contraindicated, is recommended for all patients with bioprosthetic valves. Long-term anticoagulant therapy, unless contraindicated, is recommended for all patients with bioprosthetic valves who have risk factors for thromboembolism. Please see the Instructions for Use (IFU) for a full description of indications, contraindications, side effects, precautions, warnings and Instructions for Use. Unless otherwise noted, ™ indicates that the name is a trademark of, or licensed to, St. Jude Medical or one of its subsidiaries. ST. JUDE MEDICAL and the nine-squares symbol are trademarks and service marks of St. Jude Medical, Inc. and its related companies. © 2015 St. Jude Medical, Inc. All Rights Reserved.

Product referenced is approved for CE Mark.

SJM-TRF-1214-0015(2)b | Item approved for international use.

Exhibition hall EXHIBITION TIMES Thursday March 10 Friday March 11

08.00 - 16.30 08.00 - 14.00

Plenary room Preview Table future meeting

Desk

Buffet

1 2

3

Booth Company 1 2 3 4 5

Buffet

5

Cloakroom

4

Abbott Vascular

GE Healthcare Medtronic LivaNova St. Jude Medical

ACKNOWLEDGEMENTS 2016

office

Notes ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ......................................................................

...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ......................................................................

Visa Mdeon n° 16/V2/8598/004974

www.eurovalvecongress.com ORGANIZATION: divine [id] agency • Stéphanie Meyer: smeyer@divine-id.com • Mob. +33 (0) 646 10 48 26 •V érane Bergeron Moreau: vbergeron@divine-id.com • 17, rue Venture - 13001 Marseille, France • Tel. +33 (0) 491 57 19 60 • Fax +33 (0) 491 57 19 61 • www.divine-id.com